Target intelligence / Profile preview

Endoplasmic reticulum metallopeptidase 1 (ERMP1)

Target
ERMP1
Molecular classification
Enzyme, Metallopeptidase (M28 family), Membrane protein
01

Overview

Endoplasmic reticulum metallopeptidase 1 (ERMP1) is a zinc-dependent, membrane-bound metallopeptidase of the M28 family, localized to the endoplasmic reticulum. It is broadly expressed in several human cancers and is crucial for mediating the unfolded protein response (UPR) and cellular defense against oxidative stress. ERMP1 supports cancer cell proliferation, migration, and invasiveness under stress by promoting activation of UPR sensors (such as PERK) and induction of stress chaperones (such as GRP78/BiP). In the ovary, ERMP1 is required for follicle organization. High ERMP1 expression is associated with tumorigenesis and may serve as a biomarker and potential therapeutic target for anti-cancer strategies, particularly those disrupting UPR mechanisms in tumors[1][2][3][4].

Other names
FLJ23309FXNAKIAA1815FxnAFelix-inaaminopeptidase FxnabA207C16.3
02

Mechanism of action

Inhibition of ERMP1 impairs the UPR and oxidative stress response in cancer cells, potentially sensitizing them to stress and blocking survival pathways[1][2][3]. (No specific drugs yet identified that directly inhibit ERMP1; mechanisms are theoretical and based on gene silencing or antibody strategies.)

03

Biological functions

Unfolded protein response (UPR)Cellular response to oxidative stressCell proliferationCell migrationCell invasivenessOrganization of ovarian follicles
04

Disease associations

Cancer (including breast, colorectal, lung, and ovarian cancers)TumorigenesisPotential cancer biomarker
05

Safety considerations

Targeting ERMP1 could affect normal tissue homeostasis in organs that rely on the UPR or oxidative stress protectionpossible effects on ovarian follicle organization and reproductive healthgeneral risk of disturbing cellular protein folding and redox homeostasis[2]
06

Biomarkers

ERMP1 protein expression (potential biomarker for multiple cancers)GRP78/BiP induction (UPR status surrogate)[1][2]

Beyond the preview

Go deeper on Endoplasmic reticulum metallopeptidase 1 (ERMP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endoplasmic reticulum metallopeptidase 1 (ERMP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call